Lyme disease - Current state of knowledge;Lyme-borreliose - Aktueller kenntnisstand

Deutsches Arzteblatt

Volumn 106, Issue 5, 2009, Pages 72-82

  Nau, Roland ^a,c   Christen, Hans Jürgen ^b   Eiffert, Helmut ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b KINDERKRANKENHAUS AUF DER BULT   (Germany)

^c Sleep Laboratory   (Germany)

Author keywords

Antibiotic; Borreliosis; Laboratory diagnosis; Lyme disease; Tick bite

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; BACTERIUM ANTIBODY; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; DOXYCYCLINE; MACROLIDE; PENICILLIN G; PLACEBO;

ACRODERMATITIS CHRONICA ATROPHICANS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ARTHRITIS; ARTICLE; ATAXIA; BLADDER DISEASE; BORRELIA BURGDORFERI; BORRELIA INFECTION; BRAIN INFECTION; BRAIN VASCULITIS; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DYSARTHRIA; ENCEPHALITIS; ERYTHEMA; ERYTHEMA CHRONICUM MIGRANS; EUROPE; EXHAUSTION; EXTRAPYRAMIDAL SYNDROME; FACIAL NERVE PARALYSIS; FATIGUE; FLACCID PARALYSIS; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; IRITIS; IXODES RICINUS; LYME DISEASE; LYMPHOCYTOMA; LYMPHOCYTOSIS; MEDICAL LITERATURE; MENINGITIS; MYALGIA; MYELITIS; MYOCARDITIS; MYOSITIS; NEURITIS; NORTH AMERICA; PARAPLEGIA; PERICARDITIS; PERSONALITY DISORDER; POLYMERASE CHAIN REACTION; POLYNEUROPATHY; PRACTICE GUIDELINE; PROTECTIVE CLOTHING; RADICULITIS; SENSORY DYSFUNCTION; SERODIAGNOSIS; SKIN BIOPSY; SUN EXPOSURE; TICK; TICK BITE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULITIS;

CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LYME DISEASE;

EID: 60749113727     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0072     Document Type: Article

References (25)

1. Satz N: Klinik der Lyme-Borreliose. Verlag Hans Huber, Bern, 2. Auflage, 2002.
2. Lünemann JD, Gelderblom H, Sospedra M, Quandt JA, Pinilla C, Marques A, Martin R: Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early Lyme encephalitis. Infect Immun 2007; 75: 243-51.
3. Ohlenbusch A, Matuschka F-R, Richter D, Christen H-J, Thomssen R, Spielman A, Eiffert H: Etiology of the Acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis 1996; 174: 421-3.
4. Wilske B, Busch U, Eiffert H, Fingerle V, Pfister HW, Rössler D, Preac-Mursic V: Diversitiy of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol 1996; 184: 195-201.
5. Robert-Koch-Institut. RKI Ratgeber Infektionskrankheiten "Lyme-Borreliose" 2007. http://www.rki.de/nn-466802/DE/Content/Infekt/ EpidBull/Merkblaetter/Ratgeber-Mbl-LymeBorreliose.html
6. Wilske B, Fingerle V: Lyme-Borreliose Diagnostik. Mikrobiologe 2005; 15: 209-20.
7. Huppertz HI, Böhme M, Standaert SM, Karch H, Plotkin SA: Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 697-703.
8. Christen H-J, Eiffert H: Lyme-Borreliose: Haut- und Nervensystem. Monatschr Kinderheilk 2003; 151: 1146-55.
9. Christen HJ, Hanefeld F, Eiffert H, Thomssen R: Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl 1993; 386: 1-75.
10. Ackermann R, Golmer E, Rehse-Küpper B: Progressive Borrelien-Enzephalomyelitis. Dtsch Med Wochenschr 1985; 110: 1039-42.
11. Miklossy J, Kuntzer T, Bogousslavsky J, Regli F, Janzer RC: Meningovascular form of neuroborreliosis: similarities between neuropathological findings in a case of Lyme disease and those occurring in tertiary neurosyphilis. Acta Neuropathol 1990; 80: 568-72.
12. Eiffert H, Karsten A, Schlott T, Ohlenbusch A, Laskawi R, Hoppert M, Christen HJ: Acute peripheral facial palsy in Lyme disease - a distal neuritis at the infection site. Neuropediatrics 2004; 35: 267-73.
13. Wilske B, Zöller L, Brade V, Eiffert H, Göbel UB, Stanek G, Pfister HW: MiQ12 2000 Lyme-Borreliosis http://www.dghm.org/red/index.html? cname=MIQ
14. Kaiser R, Kölmel HW, Pfister HW, Rauer S, Wilske B: Neuroborreliose (Leitlinie der Deutschen Gesellschaft für Neurologie). In Diener HC et al. (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie, 3. Aufl, Thieme, Stuttgart 2005.
15. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP: Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18: 484-509.
16. Kaiser R: Verlauf der akuten und chronischen Neuroborreliose nach Behandlung mit Ceftriaxon. Nervenarzt 2004; 75: 553-7.
17. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC et al.: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis and babesiosis: Clinical practice guidelines by the infectious diseases society of America. IDSA Giudelines 2006; 43: 1089-134.
18. Feder HM, Johnson BJB, O'Connell et al.: A critical appraisal of .,chronic lyme disease". N Engl J Med 2007; 357: 1422-30.
19. Nau R, Prange HW, Muth P, Mahr G, Menck S, Kolenda H, Sörgel F: Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 1993; 37: 1518-24.
20. Krupp LB, Masur D, Schwartz J, Coyle PK, Langenbach LJ, Fernquist SK, Jandorf L, Halperin JJ: Cognitive function in late Lyme borreliosis. Arch Neurol 1991; 48: 1125-9.
21. Auwaerter PG: Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to lyme disease. Clin Infect Dis 2007; 45: 143-8.
22. Krupp LB, Hyman LG, Grimson R et al.: Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003; 60: 1923-30.
23. Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED: Long-term outcomes of persons with Lyme disease. J Am Med Assoc 2000; 283: 609-16.
24. Stricker RB. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease. Clin Infect Dis 2007; 45: 149-57.
25. Eiffert H, Karsten A, Ritter K, Ohlenbusch A, Schlott T, Laskawi R, Christen HJ: Autoantibodies to human manganese superoxide dismutase (MnSOD) in children with facial palsy due to neuroborreliosis. Neuropediatrics 2005; 36: 386-8.